Efficacy of prophylactic dexmedetomidine in preventing Emergence Agitation in Children undergoing vascular interventional surgery: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900021325

Enrollment

Unknown

Registered

2019-02-15

Start date

2019-02-25

Completion date

Unknown

Last updated

2019-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric post-anesthesia emergence agitation

Interventions

Control group:none

Intranasal group:Intranasal dexmedetomidine

Intravenous group:Intravenous dexmedetomidine

Eligibility

Sex/Gender

All

Age

2 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. Aged 2 to 10 years; 2. ASA I to III; 3. Angiography or vascular interventional surgery.

Exclusion criteria

Exclusion criteria: 1. Allergy to dexmedetomidine; 2. Severe development delay; 3. Severe facial or airway abnormal.

Design outcomes

Primary

Measure	Time frame
The incidence of Emergence Agitation in PACU;	—

Secondary

Measure	Time frame
The incidence of Emergence Agitation in ward;	—

Countries

China

Contacts

Public ContactHuang Lei

Kunming Children's Hospital

65255106@qq.com+86 18087347480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026